Bojing Liu1, Zhehui Luo2, Jayant M Pinto3, Eric J Shiroma4, Gregory J Tranah5, Karin Wirdefeldt6, Fang Fang6, Tamara B Harris4, Honglei Chen2. 1. Karolinska Institutet, Stockholm, Sweden, and Michigan State University College of Human Medicine, East Lansing, Michigan (B.L.). 2. Michigan State University College of Human Medicine, East Lansing, Michigan (Z.L., H.C.). 3. The University of Chicago, Chicago, Illinois (J.M.P.). 4. National Institute on Aging of the National Institutes of Health, Bethesda, Maryland (E.J.S., T.B.H.). 5. California Pacific Medical Center Research Institute, San Francisco, California (G.J.T.). 6. Karolinska Institutet, Stockholm, Sweden (K.W., F.F.).
Abstract
Background: Poor olfaction is common among older adults and has been linked to higher mortality. However, most studies have had a relatively short follow-up and have not explored potential explanations. Objective: To assess poor olfaction in relation to mortality in older adults and to investigate potential explanations. Design: Community-based prospective cohort study. Setting: 2 U.S. communities. Participants: 2289 adults aged 71 to 82 years at baseline (37.7% black persons and 51.9% women). Measurements: Brief Smell Identification Test in 1999 or 2000 (baseline) and all-cause and cause-specific mortality at 3, 5, 10, and 13 years after baseline. Results: During follow-up, 1211 participants died by year 13. Compared with participants with good olfaction, those with poor olfaction had a 46% higher cumulative risk for death at year 10 (risk ratio, 1.46 [95% CI, 1.27 to 1.67]) and a 30% higher risk at year 13 (risk ratio, 1.30 [CI, 1.18 to 1.42]). Similar associations were found in men and women and in white and black persons. However, the association was evident among participants who reported excellent to good health at baseline (for example, 10-year mortality risk ratio, 1.62 [CI, 1.37 to 1.90]) but not among those who reported fair to poor health (10-year mortality risk ratio, 1.06 [CI, 0.82 to 1.37]). In analyses of cause-specific mortality, poor olfaction was associated with higher mortality from neurodegenerative and cardiovascular diseases. Mediation analyses showed that neurodegenerative diseases explained 22% and weight loss explained 6% of the higher 10-year mortality among participants with poor olfaction. Limitation: No data were collected on change in olfaction and its relationship to mortality. Conclusion: Poor olfaction is associated with higher long-term mortality among older adults, particularly those with excellent to good health at baseline. Neurodegenerative diseases and weight loss explain only part of the increased mortality. Primary Funding Source: National Institutes of Health and Michigan State University.
Background: Poor olfaction is common among older adults and has been linked to higher mortality. However, most studies have had a relatively short follow-up and have not explored potential explanations. Objective: To assess poor olfaction in relation to mortality in older adults and to investigate potential explanations. Design: Community-based prospective cohort study. Setting: 2 U.S. communities. Participants: 2289 adults aged 71 to 82 years at baseline (37.7% black persons and 51.9% women). Measurements: Brief Smell Identification Test in 1999 or 2000 (baseline) and all-cause and cause-specific mortality at 3, 5, 10, and 13 years after baseline. Results: During follow-up, 1211 participantsdied by year 13. Compared with participants with good olfaction, those with poor olfaction had a 46% higher cumulative risk for death at year 10 (risk ratio, 1.46 [95% CI, 1.27 to 1.67]) and a 30% higher risk at year 13 (risk ratio, 1.30 [CI, 1.18 to 1.42]). Similar associations were found in men and women and in white and black persons. However, the association was evident among participants who reported excellent to good health at baseline (for example, 10-year mortality risk ratio, 1.62 [CI, 1.37 to 1.90]) but not among those who reported fair to poor health (10-year mortality risk ratio, 1.06 [CI, 0.82 to 1.37]). In analyses of cause-specific mortality, poor olfaction was associated with higher mortality from neurodegenerative and cardiovascular diseases. Mediation analyses showed that neurodegenerative diseases explained 22% and weight loss explained 6% of the higher 10-year mortality among participants with poor olfaction. Limitation: No data were collected on change in olfaction and its relationship to mortality. Conclusion: Poor olfaction is associated with higher long-term mortality among older adults, particularly those with excellent to good health at baseline. Neurodegenerative diseases and weight loss explain only part of the increased mortality. Primary Funding Source: National Institutes of Health and Michigan State University.
Authors: Davangere P Devanand; Seonjoo Lee; Jennifer Manly; Howard Andrews; Nicole Schupf; Arjun Masurkar; Yaakov Stern; Richard Mayeux; Richard L Doty Journal: Ann Neurol Date: 2015-07-03 Impact factor: 10.422
Authors: Claire Murphy; Carla R Schubert; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; David M Nondahl Journal: JAMA Date: 2002-11-13 Impact factor: 56.272
Authors: Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Rachel A Murphy; Anne B Newman; Douglas C Bauer; Tamara B Harris; Zhou Yang; William B Applegate; Stephen B Kritchevsky Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: D Berg; J Godau; K Seppi; S Behnke; I Liepelt-Scarfone; S Lerche; H Stockner; A Gaenslen; P Mahlknecht; H Huber; K Srulijes; J Klenk; K Fassbender; W Maetzler; W Poewe Journal: Eur J Neurol Date: 2012-08-01 Impact factor: 6.089
Authors: Marie-Elyse Lafaille-Magnan; Judes Poirier; Pierre Etienne; Jennifer Tremblay-Mercier; Joanne Frenette; Pedro Rosa-Neto; John C S Breitner Journal: Neurology Date: 2017-06-28 Impact factor: 9.910
Authors: Frank Purdy; Zhehui Luo; Joseph C Gardiner; Jayant M Pinto; Eric J Shiroma; Eleanor M Simonsick; Tamara B Harris; Honglei Chen Journal: J Gerontol A Biol Sci Med Sci Date: 2020-11-13 Impact factor: 6.053
Authors: Ayat A Awwad; Osama M M Abd Elhay; Moustafa M Rabie; Eman A Awad; Fatma M Kotb; Hend M Maghraby; Rmadan H Eldamarawy; Yahia M A Dawood; Mostafa I E I Balat; Ahmed I M Hasan; Ahmed H Elsheshiny; Said S M M El Sayed; Albayoumi A B Fouda; Ahmad M F Alkot Journal: Int J Gen Med Date: 2022-06-17
Authors: Natalie Yan-Lin Pang; Harris Jun Jie Muhammad Danial Song; Benjamin Kye Jyn Tan; Jun Xiang Tan; Ashley Si Ru Chen; Anna See; Shuhui Xu; Tze Choong Charn; Neville Wei Yang Teo Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-05-01 Impact factor: 8.961
Authors: Jordan J Allensworth; Rodney J Schlosser; Timothy L Smith; Jess C Mace; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2021-12-18 Impact factor: 5.426
Authors: Siddharth Raj; Anbupalam Thalamuthu; Nicola J Armstrong; Margaret J Wright; John B Kwok; Julian N Trollor; David Ames; Peter R Schofield; Henry Brodaty; Perminder S Sachdev; Karen A Mather Journal: Genes (Basel) Date: 2021-04-29 Impact factor: 4.096
Authors: Jose L Mattos; Zachary M Soler; Rodney J Schlosser; Jess C Mace; Jeremiah A Alt; Vijay R Ramakrishnan; Spencer C Payne; Timothy L Smith; Daniel M Beswick Journal: Am J Rhinol Allergy Date: 2020-09-20 Impact factor: 2.467
Authors: Honglei Chen; Dale P Sandler; Srishti Shrestha; David M Umbach; Laura E Beane Freeman; Stella Koutros; Michael C R Alavanja; Aaron Blair Journal: Occup Environ Med Date: 2020-10-23 Impact factor: 4.402